Printer Friendly

Medications to be avoided by Parkinson patients.

Medications To Be Avoided
By Parkinson Patients

Drug Category                         Trade Name           Generic Name

Antipsychotic (used for                   Haldol           Haloperiodol
agitated confusion)                     Trilafon           Perphenazine
                                       Thorazine         Chlorpromazine
                                       Stelazine        Trifluoperazine
                              Prolixin, Permitil            Flufenazine
                                          Navane            Thiothixene
                          Mellaril (high dosage)           Thioridazine

Antidepressant                           Triavil         Combination of
                                                         Perphenazine &
                                                          Amitriptyline
                                          Nardil             Phenelzine
                                         Parnate        Tranylcypromine

Antivomiting                           Compazine       Prochlorperazine
                                          Reglan         Metoclopramide
                                         Torecan       Thiethylperazine

Miscellaneous                           Serpasil              Reserpine

Blood Pressure                          Raudixin   Rauwolfia Serpentina

Postoperative                           Rauverid                   None
Medication                               Wolfina                   None
                                        Harmonyl              Deserpine
                                         Moderil           Rescinnamine
                                       Rauwiloid                   None

Possible                                 Aldomet       Alpha-methyldopa

Potential                               Dilantin              Phenytoin
                            Lithane (and others)                Lithium
                                          Buspar              Buspirone

Based on The American Parkinson Disease Newsletter (Spring 1990),
60 Bay Street, Staten Island, New York 10301. By Permission of Paul
A. Nausiedo. M.D., Director of the APDA Information and Referral
Center, Milwaukee, Wisconsin.
COPYRIGHT 2003 Vegetus Publications
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nutrition Health Review
Article Type:Illustration
Geographic Code:1USA
Date:Mar 22, 2003
Words:119
Previous Article:Kuru, a meat-eating disease that affects cannibals.
Next Article:KI pills may be dangerous.
Topics:


Related Articles
Neurons slow down for placebo effect.
Hallucinations are not 'benign' in Parkinson's disease.
Reward-based behavior common in Parkinson's.
MAO inhibitor is approved for Parkinson's.
Head to head: brain implants are better for Parkinson's patients.
Brain stimulation eases Parkinson's symptoms: patients on implants and medication regimen saw improvements in quality of life, motor function.
Infections, drug changes can bring Parkinson's to the ED.
Gene therapy helps Parkinson's in phase I trial.
Parkinson's disease medication may trigger compulsive gambling, hypersexuality.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters